Shipping Stability This product is shipped with medical-grade thermal packaging
F.GarciaW.MunizJ
: Oral GLP-1s could unlock a $100B+ opportunity, offering scalable solutions in diabetes, obesity, and beyond
Across 67 insurance threads I reviewed on r/Zepbound, r/CPAP, r/SleepApnea and eight other subreddits (October 2024 to July 2026), the OSA indication was the most cited coverage route: 32 threads describe approvals, formulary exceptions, or appeal wins that hung on moderate-to-severe OSA documentation, including an eight-month formulary-exception fight won at UHC/Optum on a plan that excluded weight loss
We only succeed when employers and their employees do, too." To mark the announcement of these new products, which will be available in January, Noom also published a whitepaper today Breaking the GLP-1 Cost Cycle: Transforming Access, Cutting Costs, and Shaping the Future of Obesity Care which is available here: For more information about Nooms enterprise offerings, please visit noom.com/health
330, no